These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 2154418

  • 1. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
    Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
    [Abstract] [Full Text] [Related]

  • 2. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
    [Abstract] [Full Text] [Related]

  • 3. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
    Prados MD, Scott C, Curran WJ, Nelson DF, Leibel S, Kramer S.
    J Clin Oncol; 1999 Nov; 17(11):3389-95. PubMed ID: 10550132
    [Abstract] [Full Text] [Related]

  • 4. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
    Jeremic B, Jovanovic D, Djuric LJ, Jevremovic S, Mijatovic LJ.
    J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
    [Abstract] [Full Text] [Related]

  • 5. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
    Gundersen S, Lote K, Watne K.
    Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629
    [Abstract] [Full Text] [Related]

  • 6. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S, Talari G, Rosenfeld M, Guo J, Villano JL.
    Cochrane Database Syst Rev; 2017 Jul 26; 7(7):CD011773. PubMed ID: 28744879
    [Abstract] [Full Text] [Related]

  • 7. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR.
    Clin Cancer Res; 2000 Oct 26; 6(10):3878-84. PubMed ID: 11051233
    [Abstract] [Full Text] [Related]

  • 8. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
    Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):57-63. PubMed ID: 9422558
    [Abstract] [Full Text] [Related]

  • 9. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
    Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M.
    J Clin Oncol; 2009 Dec 10; 27(35):5874-80. PubMed ID: 19901110
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA, Lamborn K, Wara W, Davis R, Edwards M, Rabbitt J, Malec M, Prados MD.
    Neuro Oncol; 2000 Jan 10; 2(1):22-8. PubMed ID: 11302250
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT, Wei KC, Tseng CK, Jung SM.
    Chang Gung Med J; 2005 Jan 10; 28(1):16-23. PubMed ID: 15804144
    [Abstract] [Full Text] [Related]

  • 12. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
    Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ.
    Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1109-15. PubMed ID: 10613302
    [Abstract] [Full Text] [Related]

  • 13. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson CB.
    Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):75-83. PubMed ID: 7721642
    [Abstract] [Full Text] [Related]

  • 14. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
    Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P.
    Int J Radiat Oncol Biol Phys; 1991 Aug 30; 21(3):601-6. PubMed ID: 1651302
    [Abstract] [Full Text] [Related]

  • 15. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1147-52. PubMed ID: 15001257
    [Abstract] [Full Text] [Related]

  • 16. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 17. Northern California Oncology Group protocol 6G91: response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme.
    Levin VA, Wara WM, Davis RL, Silver P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    Cancer Treat Rep; 1986 Jun 01; 70(6):739-43. PubMed ID: 3015402
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH.
    Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):58-66. PubMed ID: 12007942
    [Abstract] [Full Text] [Related]

  • 19. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
    Levin VA.
    Oncology (Williston Park); 2015 Apr 01; 29(4):264, 266-8. PubMed ID: 25952490
    [No Abstract] [Full Text] [Related]

  • 20. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
    Kyritsis AP, Yung WK, Jaeckle KA, Bruner J, Gleason MJ, Ictech SE, Flowers A, Levin VA.
    Neurosurgery; 1996 Nov 01; 39(5):921-6. PubMed ID: 8905746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.